MSInsight

MSInsight: Founded by Doctors and Engineers to Support Oncologists in Choosing the Right Treatment for Each Cancer PatientMSInsight was founded by doctors and engineers with the mission of supporting oncologists in selecting the appropriate treatment for each cancer patient. The company develops diagnostic solutions to identify crucial information within a patient's DNA, predicting the success of treatments. Specifically, the company is revolutionizing the diagnosis of microsatellite instability (MSI), a type of DNA alteration that, if found in patients, qualifies them for immunotherapy. Thanks to 20 years of academic research from Inserm, AP-HP, and Sorbonne University, MSInsight aims to provide more accurate diagnostics, making this treatment pathway accessible.